Reda, S.; Rudde, E.; Müller, J.; Hamedani, N.S.; Oldenburg, J.; Pötzsch, B.; Rühl, H.
Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism. Life 2022, 12, 705.
https://doi.org/10.3390/life12050705
AMA Style
Reda S, Rudde E, Müller J, Hamedani NS, Oldenburg J, Pötzsch B, Rühl H.
Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism. Life. 2022; 12(5):705.
https://doi.org/10.3390/life12050705
Chicago/Turabian Style
Reda, Sara, Eva Rudde, Jens Müller, Nasim Shahidi Hamedani, Johannes Oldenburg, Bernd Pötzsch, and Heiko Rühl.
2022. "Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism" Life 12, no. 5: 705.
https://doi.org/10.3390/life12050705
APA Style
Reda, S., Rudde, E., Müller, J., Hamedani, N. S., Oldenburg, J., Pötzsch, B., & Rühl, H.
(2022). Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism. Life, 12(5), 705.
https://doi.org/10.3390/life12050705